TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
B/P-Pharma AB
Closing information (x1000 EUR)
| Closing information | 2023/04 | 2022/04 | 2021/04 |
| Turnover |
1,120
|
1,148
|
1,156 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
29
|
31
|
16 |
| EBITDA |
48
|
32
|
18 |
| Total assets |
453
|
455
|
469 |
| Current assets |
381
|
453
|
466 |
| Current liabilities |
129
|
127
|
161 |
| Equity capital |
301
|
306
|
286 |
| - share capital |
4
|
5
|
5 |
| Employees (average) |
3
|
3
|
3 |
Financial ratios
| Fiscal year | 2023/04 | 2022/04 | 2021/04 |
| Solvency |
66.4%
|
67.3%
|
61.0% |
| Turnover per employee |
373
|
383
|
385 |
| Profit as a percentage of turnover |
2.6%
|
2.7%
|
1.4% |
| Return on assets (ROA) |
6.4%
|
6.8%
|
3.4% |
| Current ratio |
295.3%
|
356.7%
|
289.4% |
| Return on equity (ROE) |
9.6%
|
10.1%
|
5.6% |
| Change turnover |
75
|
10
|
16 |
| Change turnover % |
7%
|
1%
|
1% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/04 | 2022/04 | 2021/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.